Sexual dysfunction and depression

Abstract

Sexual functioning is generally impaired during depression. Interest in the relationship between sexual dysfunction and depression has risen substantially, prompted primarily by 1) the 1998 Food and Drug Administration approval of sildenafil citrate as the first oral therapy of erectile dysfunction, and 2) the widespread clinical use of selective serotonin reuptake inhibitors, which prominently impair orgasm, and possibly libido and arousal. In this paper, we first review the phenomenology of sexual dysfunction and important contributing factors, such as age and illness, and then focus on the clinical assessment and therapeutic interventions used for sexual dysfunction in depressed individuals.

Preview

References and Recommended Reading

1.

Basson R, Berman J, Burnett A, et al.: Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000, 163:888–893. The report of an international, multidisciplinary consensus development conference that was held in the United States to develop a new classification system to apply to all forms of FSD, regardless of etiology. Major categories of FSD include desire disorders, arousal disorders, orgasm disorders, and sexual pain problems.PubMedCrossRefGoogle Scholar

Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999, 281:537–544. Summary report and reanalysis of the National Health and Social Life Survey, the most comprehensive national study of sexual behavior in the United States since Kinsey.PubMedCrossRefGoogle Scholar

4.

Sherwin BB, Gelfand MM: The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987, 49:397–409.PubMedGoogle Scholar

5.

Seidman SN: Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women. Curr Psychiatry Rep 2000, 2:215–222.PubMedCrossRefGoogle Scholar

Araujo AB, Durante R, Feldman HA, et al.: The relationship between depressive symptoms and male erectile dysfunction: Cross sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998, 60:458–465. This is an important report that uses a large, representative epidemiologic sample to confirm the strong association between self-reported depressive symptoms and ED. Although it cannot address causality, it is the first study to suggest that depression is a risk factor for ED of equal magnitude to the more commonly acknowledged factors, such as cardiovascular morbidity and diabetes.PubMedGoogle Scholar

Seidman SN, Roose SP, Shabsigh R, et al.: Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry2001, in press. A study in which men with depression and ED were randomized to receive sildenafil or placebo. Of particular importance was the finding that men who had an improvement in ED, whether they received sildenafil or placebo, had a substantial improvement in depression.Google Scholar